EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RNA-binding protein RBM34 promotes hepatic fibrosis by enhancing DROSHA-mediated nuclear export of Loxl2 mRNA

Ya-Rui Hou, Li-Ting Diao, Shu-Juan Xie, Jin Zeng, Hui-Shan Lai, Guo Lv, Yan-Xia Hu, Min-Chang Liang, Tu-Cheng Huang, Zhen-Dong Xiao, Qi Zhang

Cell Reports · 2026-11 · 45 (11) · 118202

DOI: 10.1016/j.celrep.2026.118202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Ya-Rui Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, P.R. China. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic fibrosis is driven by excessive extracellular matrix (ECM) deposition from activated hepatic stellate cells (HSCs). Although RNA-binding proteins (RBPs) are emerging as key regulators of HSC activation, the role of RBM34 in liver fibrosis remains unexplored. Here we show that RBM34 is markedly upregulated in human and murine fibrotic livers, predominantly in activated HSCs, and is potently induced by TGFβ. RBM34 enhances fibrotic marker expression and HSC contractility, and HSC-specific knockdown attenuates liver fibrosis in vivo. Mechanistically, STAMP (survey targets by APOBEC-mediated profiling) and RNA immunoprecipitation (RIP) analyses identified lysyl oxidase-like 2 (Loxl2) mRNA as a direct RBM34 target. RBM34 interacts with DROSHA to promote nuclear export and translation of Loxl2 mRNA independently of DROSHA's canonical RNase III activity. Collectively, these findings uncover a non-canonical role for DROSHA in mRNA trafficking and establish the RBM34-DROSHA-LOXL2 axis as a driver of hepatic fibrogenesis, highlighting RBM34 as a potential therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

CP: molecular biologyDROSHARBM34hepatic fibrosishepatic stellate cellsubcellular distribution

Autor:innen und Institutionen

  • Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, P.R. China.
  • Institute of Vaccine, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, P.R. China.
  • Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, P.R. China.
  • Yew Wah International Education School of Guangzhou, Guangzhou 510897, P.R. China.
  • Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510000, China; Laboratory of Cardiac Electrophysiology and Arrhythmia in Guangdong Province, Guangzhou 510000, China.
  • Biotherapy Center, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, P.R. China; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzho…

Zitieren

APA

Hou, Y. R., Diao, L. T., Xie, S. J., Zeng, J., Lai, H. S., Lv, G., Hu, Y. X., Liang, M. C., Huang, T. C., Xiao, Z. D., & Zhang, Q. (2026). RNA-binding protein RBM34 promotes hepatic fibrosis by enhancing DROSHA-mediated nuclear export of Loxl2 mRNA. Cell Reports, 45(11), 118202. https://doi.org/10.1016/j.celrep.2026.118202

Vancouver

Hou YR, Diao LT, Xie SJ, Zeng J, Lai HS, Lv G, et al. RNA-binding protein RBM34 promotes hepatic fibrosis by enhancing DROSHA-mediated nuclear export of Loxl2 mRNA. Cell Reports. 2026;45(11):118202. doi:10.1016/j.celrep.2026.118202

BibTeX
@article{Hou2026,
  author = {Hou, Ya-Rui and Diao, Li-Ting and Xie, Shu-Juan and Zeng, Jin and Lai, Hui-Shan and Lv, Guo and Hu, Yan-Xia and Liang, Min-Chang and Huang, Tu-Cheng and Xiao, Zhen-Dong and Zhang, Qi},
  title = {RNA-binding protein RBM34 promotes hepatic fibrosis by enhancing DROSHA-mediated nuclear export of Loxl2 mRNA},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {118202},
  doi = {10.1016/j.celrep.2026.118202}
}
Kostenlos starten →